Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bidirectional allosteric interactions between cannabinoid receptor 1 (CB 1 ) and dopamine receptor 2 long (D 2L ) heterotetramers
Amina M. Bagher, Robert B. Laprairie, James Thomas Toguri, et al.
European Journal of Pharmacology (2017) Vol. 813, pp. 66-83
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
Kinga Tóth, Dorottya Ádám, Tamás Bı́ró, et al.
Molecules (2019) Vol. 24, Iss. 5, pp. 918-918
Open Access | Times Cited: 176
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction
Eric W. Fish, Laura B. Murdaugh, Chengjin Zhang, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 98
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 80
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Yifei Feng, Yan Lü
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitro
A. P. Young, Eileen M. Denovan‐Wright
Brain Behavior and Immunity (2022) Vol. 105, pp. 29-43
Closed Access | Times Cited: 23
Detergent-free extraction of a functional low-expressing GPCR from a human cell line
Juan F. Bada Juarez, Juan C. Muñoz‐García, Rosana I. Reis, et al.
Biochimica et Biophysica Acta (BBA) - Biomembranes (2019) Vol. 1862, Iss. 3, pp. 183152-183152
Open Access | Times Cited: 39
Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art
Elise Wouters, Lakshmi Vasudevan, René A. J. Crans, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2958-2958
Open Access | Times Cited: 36
Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy
Sina Pakkhesal, Mohammad Shakouri, Reza Mosaddeghi-Heris, et al.
Pharmacology & Therapeutics (2025), pp. 108799-108799
Closed Access
Endocannabinoid signaling in the central nervous system
César E. Martinez Ramirez, Gonzalo Ruiz‐Pérez, Todd M. Stollenwerk, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 5-35
Open Access | Times Cited: 16
The future of type 1 cannabinoid receptor allosteric ligands
Mariam Alaverdashvili, Robert B. Laprairie
Drug Metabolism Reviews (2018) Vol. 50, Iss. 1, pp. 14-25
Closed Access | Times Cited: 28
Heteromerization of dopaminergic receptors in the brain: Pharmacological implications
Desye Misganaw
Pharmacological Research (2021) Vol. 170, pp. 105600-105600
Closed Access | Times Cited: 21
An enquiry to the role of CB1 receptors in neurodegeneration
Ignacio Fernández‐Moncada, Abel Eraso‐Pichot, Tommaso Dalla Tor, et al.
Neurobiology of Disease (2023) Vol. 184, pp. 106235-106235
Open Access | Times Cited: 8
Biomarkers in aggression
Mirko Manchia, Stefano Comai, Martina Pinna, et al.
Advances in clinical chemistry (2019), pp. 169-237
Closed Access | Times Cited: 21
The Cannabinoid Delta-9-tetrahydrocannabinol Disrupts Estrogen Signaling in Human Placenta
J. Costa Maia, Marta Almada, Luís Midão, et al.
Toxicological Sciences (2020) Vol. 177, Iss. 2, pp. 420-430
Closed Access | Times Cited: 18
Noncanonical Activity of Endocannabinoids and Their Receptors in Central and Peripheral Synapses
О. П. Балезина, Е. О. Тарасова, А. Е. Gaydukov
Biochemistry (Moscow) (2021) Vol. 86, Iss. 7, pp. 818-832
Closed Access | Times Cited: 15
Homo-oligomerization of the human adenosine A2A receptor is driven by the intrinsically disordered C-terminus
Khanh Dinh Quoc Nguyen, Michael Vigers, Eric Sefah, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 15
Class A and C GPCR Dimers in Neurodegenerative Diseases
Irina S. Moreira, Ana B. Caniceiro, Beatriz Bueschbell, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2081-2141
Open Access | Times Cited: 10
Unmasking allosteric-binding sites: novel targets for GPCR drug discovery
Verònica Casadó-Anguera, Vicent Casadó
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 8, pp. 897-923
Closed Access | Times Cited: 10
Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model
Verònica Casadó-Anguera, Estefanía Moreno, Josefa Mallol, et al.
Pharmacological Research (2018) Vol. 139, pp. 337-347
Open Access | Times Cited: 17
Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments
Amina M. Bagher, A. P. Young, Robert B. Laprairie, et al.
Journal of Neuroscience Research (2020) Vol. 98, Iss. 12, pp. 2496-2509
Closed Access | Times Cited: 15
Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects
Maria Gallo, Estefanía Moreno, Sira Defaus, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 10, pp. 6937-6948
Open Access | Times Cited: 14
The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome
Antoni Cortés, Verònica Casadó-Anguera, Estefanía Moreno, et al.
Advances in pharmacology (2019), pp. 37-78
Closed Access | Times Cited: 11
Memory Consolidation Depends on Endogenous Hippocampal Levels of Anandamide: CB1 and M4, but Possibly not TRPV1 Receptors Mediate AM404 effects
Krislei Scienza-Martin, Fernanda N. Lotz, Querusche Klippel Zanona, et al.
Neuroscience (2022) Vol. 497, pp. 53-72
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top